Moderna's concerns about Omicron outlook spark market slump
The companies that bet on messenger RNA vaccines -- BioNTech SE and its partner Pfizer Inc. as well as Moderna -- have an advantage in that they can be swift to develop a new injection
The companies that bet on messenger RNA vaccines -- BioNTech SE and its partner Pfizer Inc. as well as Moderna -- have an advantage in that they can be swift to develop a new injection https://ift.tt/32MbQrG November 29, 2021 at 11:14PM
The companies that bet on messenger RNA vaccines -- BioNTech SE and its partner Pfizer Inc. as well as Moderna -- have an advantage in that they can be swift to develop a new injection https://ift.tt/32MbQrG November 29, 2021 at 11:14PM
Comments
Post a Comment